CROSSTALK BETWEEN THE INTERLEUKIN-6 (IL-6)-JAK-STAT AND THE GLUCOCORTICOID-NUCLEAR RECEPTOR PATHWAY - SYNERGISTIC ACTIVATION OF IL-6 RESPONSE ELEMENT BY IL-6 AND GLUCOCORTICOID
T. Takeda et al., CROSSTALK BETWEEN THE INTERLEUKIN-6 (IL-6)-JAK-STAT AND THE GLUCOCORTICOID-NUCLEAR RECEPTOR PATHWAY - SYNERGISTIC ACTIVATION OF IL-6 RESPONSE ELEMENT BY IL-6 AND GLUCOCORTICOID, Journal of Endocrinology, 159(2), 1998, pp. 323-330
Cytokines and steroid hormones use different sets of signal transducti
on pathways, which seem to be unrelated. Interleukin-6 (IL-6) uses JAK
tyrosine kinase and STAT (signal transducer and activator of transcri
ption) transcription factor. Glucocorticoid binds glucocorticoid recep
tor (GR), which is a member of the steroid receptor superfamily. We ha
ve studied the crosstalk between the IL-6-JAK-STAT and glucocorticoid-
nuclear receptor pathways. IL-6 and glucocorticoid synergistically act
ivated the IL-6 response element on the rat alpha(2)-macroglobulin pro
moter (APRE)-driven luciferase gene. The exogenous expression of GR en
hanced the synergism. The exogenous expression of dominant negative ST
ATS completely abolished the IL-6 plus glucocorticoid-induced activati
on of the APRE-luciferase gene. Tyrosine phosphorylation of STAT3 stim
ulated by IL-6 alone was not different from that by IL-6 plus glucocor
ticoid. The protein level of STAT3 was also not increased by glucocort
icoid stimulation. The time course of STAT3 tyrosine phosphorylation b
y IL-6 plus glucocorticoid was not different from that by IL-6 alone.
The synergism was studied on the two other IL-6 response elements, the
junB promoter (JRE-IL-6) and the interferon regulatory factor-1 (IRF-
1) promoter (IRF-GAS) which could be activated by STAT3. The synergist
ic activation by glucocorticoid on the IL-6-activated JRE-IL-6 and the
IRF-GAS-driven luciferase gene was not detected. Glucocorticoid did n
ot change the mobility of IL-6-induced APRE-binding proteins in a gel
shift assay. These results suggest that the synergism was through the
GR and STAT3, and the coactivation pathway which was specific for APRE
was the target of glucocorticoid.